Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.
作者信息
Öncü Işın Nur Sultan, Güler Dilara, Gürel Gülhan
机构信息
Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
出版信息
Dermatol Ther. 2021 Mar;34(2):e14806. doi: 10.1111/dth.14806. Epub 2021 Feb 24.
Abstract
摘要
相似文献
1
Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.一名疑似新型冠状病毒肺炎患者在使用羟氯喹后银屑病病情加重。
Dermatol Ther. 2021 Mar;34(2):e14806. doi: 10.1111/dth.14806. Epub 2021 Feb 24.
2
Covid-19 and exacerbation of psoriasis.新冠病毒-19与银屑病病情加重
Dermatol Ther. 2020 Jul;33(4):e13632. doi: 10.1111/dth.13632. Epub 2020 Jun 2.
3
[Erythrodermic psoriasis after COVID-19].新型冠状病毒肺炎后红皮病型银屑病
Hautarzt. 2022 Feb;73(2):156-159. doi: 10.1007/s00105-021-04931-0. Epub 2021 Dec 14.
4
A case of palmoplantar pustular psoriasis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.系统性红斑狼疮患者应用羟氯喹诱发掌跖脓疱性银屑病 1 例
Int J Rheum Dis. 2022 Oct;25(10):1200-1202. doi: 10.1111/1756-185X.14392. Epub 2022 Aug 3.
5
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?1例新型冠状病毒肺炎患者在使用奥司他韦和羟氯喹后银屑病加重：新型冠状病毒肺炎大流行后银屑病病例会增加吗？
Dermatol Ther. 2020 Jul;33(4):e13383. doi: 10.1111/dth.13383. Epub 2020 Apr 24.
6
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性（COVID-Preg）：一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
7
Hydroxychloroquine-related Rash in COVID-19 Infected Patient.新型冠状病毒肺炎感染患者的羟氯喹相关皮疹
Isr Med Assoc J. 2020 Aug;22(8):525.
8
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
9
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?一名疑似新冠肺炎患者的免疫性血栓性血小板减少性紫癜：羟氯喹是罪魁祸首还是纯属巧合？
Turk J Haematol. 2021 Jun 1;38(2):155-157. doi: 10.4274/tjh.galenos.2021.2021.0057. Epub 2021 Feb 5.
10
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.羟氯喹和氯喹在 COVID-19 中的兴衰。
J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28.
引用本文的文献
1
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease.新发触发因素背景下的红皮病型银屑病：度普利尤单抗相关及新冠病毒诱导的银屑病性疾病解析
Dermatopathology (Basel). 2025 Jun 9;12(2):17. doi: 10.3390/dermatopathology12020017.
2
Pustular psoriasis flare-up in a patient with COVID-19.新冠病毒感染者脓疱型银屑病发作。
J Cosmet Dermatol. 2021 Nov;20(11):3364-3368. doi: 10.1111/jocd.14508. Epub 2021 Oct 7.
3
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.接受免疫抑制治疗的银屑病患者接种新冠病毒疫苗：意大利全国疫苗接种运动对临床实践的影响
Dermatol Ther (Heidelb). 2021 Dec;11(6):1889-1903. doi: 10.1007/s13555-021-00610-z. Epub 2021 Sep 29.
4
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.临床皮肤病学与新冠疫情：叙述性综述
Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21.
本文引用的文献
1
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.羟氯喹对银屑病的作用：系统评价及对 COVID-19 治疗的警示。
J Am Acad Dermatol. 2020 Aug;83(2):579-586. doi: 10.1016/j.jaad.2020.05.074. Epub 2020 May 19.
2
COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.新型冠状病毒肺炎与银屑病生物制剂：高流行地区的经验——意大利伦巴第大区贝加莫市
J Am Acad Dermatol. 2020 Jul;83(1):292-294. doi: 10.1016/j.jaad.2020.04.165. Epub 2020 May 6.
3
Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.描述羟氯喹的不良皮肤作用：一项系统综述。
J Am Acad Dermatol. 2020 Aug;83(2):563-578. doi: 10.1016/j.jaad.2020.04.024. Epub 2020 Apr 11.
4
A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?1例新型冠状病毒肺炎患者在使用奥司他韦和羟氯喹后银屑病加重：新型冠状病毒肺炎大流行后银屑病病例会增加吗？
Dermatol Ther. 2020 Jul;33(4):e13383. doi: 10.1111/dth.13383. Epub 2020 Apr 24.
5
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.羟氯喹啉是氯喹毒性较低的衍生物，在体外可有效抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。
Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020.
6
Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus.系统性红斑狼疮患者中羟氯喹诱发的银屑病样红皮病
Chin Med J (Engl). 2018 Aug 5;131(15):1887-1888. doi: 10.4103/0366-6999.237411.
7
Drug-induced psoriasis: clinical perspectives.药物性银屑病：临床视角
Psoriasis (Auckl). 2017 Dec 7;7:87-94. doi: 10.2147/PTT.S126727. eCollection 2017.
8
Long-term oral azithromycin in chronic plaque psoriasis: a controlled trial.长期口服阿奇霉素治疗慢性斑块状银屑病：一项对照试验。
Eur J Dermatol. 2010 May-Jun;20(3):329-33. doi: 10.1684/ejd.2010.0930. Epub 2010 Mar 19.
Zotero 插件